About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5485403
Allelic
Composition
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hdac1tm1.1Shmc mutation (0 available); any Hdac1 mutation (37 available)
Hdac2tm1.1Shmc mutation (0 available); any Hdac2 mutation (39 available)
Tg(Lck-cre)1Cwi mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all mice die at an average of 15 weeks

immune system
• in neonates and at 6 weeks
• in the thymus and spleen
• effacement of medullary and cortical substructures in diseased thymus
• massively in diseased mice due to overpopulation with immature and double positive T cells
• 2-fold reduction in mature TCRbetahigh/CD5high thymocytes at 10 to 14 days
• 3-fold increase immature TCRbetaint/CD5low thymocytes at 10 to 14 days
• massively in diseased mice due to overpopulation with immature and double positive T cells
• 2.6-fold reduction at 10 to 14 days
• increase in CD4low/CD8high cells at 6 to 8 weeks
• 10-fold increase in absolute number of CD4low/CD8high cells at 10 to 14 days
• block at the double negative to double positive transition
• defects in positive selection and CD4 lineage commitment
• 4-fold increase in the percent of immature single positive cells at 6 to 8 weeks

neoplasm
• with general hyperproliferation of immature T cells and infiltration into nonlymphatic organs (lung, liver and kidney)

growth/size/body
• in moribund mice
• in moribund mice
• massively in diseased mice due to overpopulation with immature and double positive T cells

respiratory system

cellular
• in tumor cells
• in tumor cells
• in neonates and at 6 weeks
• in the thymus and spleen
• in tumorigenic T cells

hematopoietic system
• in neonates and at 6 weeks
• in the thymus and spleen
• effacement of medullary and cortical substructures in diseased thymus
• massively in diseased mice due to overpopulation with immature and double positive T cells
• 2-fold reduction in mature TCRbetahigh/CD5high thymocytes at 10 to 14 days
• 3-fold increase immature TCRbetaint/CD5low thymocytes at 10 to 14 days
• massively in diseased mice due to overpopulation with immature and double positive T cells
• 2.6-fold reduction at 10 to 14 days
• increase in CD4low/CD8high cells at 6 to 8 weeks
• 10-fold increase in absolute number of CD4low/CD8high cells at 10 to 14 days
• block at the double negative to double positive transition
• defects in positive selection and CD4 lineage commitment
• 4-fold increase in the percent of immature single positive cells at 6 to 8 weeks

endocrine/exocrine glands
• in neonates and at 6 weeks
• effacement of medullary and cortical substructures in diseased thymus
• massively in diseased mice due to overpopulation with immature and double positive T cells
• 2-fold reduction in mature TCRbetahigh/CD5high thymocytes at 10 to 14 days
• 3-fold increase immature TCRbetaint/CD5low thymocytes at 10 to 14 days


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory